AIRS

AirSculpt Technologies, Inc., through its wholly owned subsidiaries, is a provider of practice management services to professional associations (PAs) located throughout the United States, Canada, and the United Kingdom. The Company owns and operates non-clinical assets and provides its management services to the PAs through management services agreements (MSAs). It operates through the direct medical procedure services segment. The Company offers fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. Its AirSculpt + procedure permanently removes fat and tightens the skin with unparalleled precision and finesse.

Wall Street analysts forecast AIRS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AIRS is 5.00 USD with a low forecast of 5.00 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

AirSculpt Technologies Inc revenue for the last quarter amounts to 34.99M USD, decreased -17.76 % YoY.

AirSculpt Technologies Inc. EPS for the last quarter amounts to -0.15 USD, increased 50.00 % YoY.

AirSculpt Technologies Inc (AIRS) has 389 emplpoyees as of December 15 2025.

Today AIRS has the market capitalization of 162.34M USD.